Author

R. C. Day

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

C. Horne· 1 shared G. Gimenez· 1 shared I. M. Morison· 1 shared J. Antony· 1 shared J. Horsfield· 1 shared J. M. Murphy· 1 shared M. Pudjihartono· 1 shared P. D. Mace· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

C. Horne

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Nanobodies identify an activated state of the TRIB2 pseudokinase

S. A. Jamieson, M. Pudjihartono, C. Horne, R. C. Day, J. M. Murphy, P. D. Mace

This study identifies nanobodies that recognize an activated conformation of TRIB2 pseudokinase, revealing structural insights and potential for inhibitor development.

bioRxiv · Apr 29, 2022Biochemistry

BET inhibition prevents aberrant RUNX1 and ERG transcription in STAG2 mutant leukaemia cells.

J. Antony, G. Gimenez, T. Taylor, U. Khatoon, R. C. Day, I. M. Morison, J. Horsfield

This study shows that BET inhibition reduces aberrant RUNX1 and ERG transcription in STAG2 mutant leukemia cells by blocking enhancer-driven gene expression during differentiation.

bioRxiv · Sep 10, 2019Cancer Biology